BIAF logo
BIAF NASDAQ US

bioAffinity Technologies, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Aug 2022
$3.92
▼ $-0.06 (-1.51%)
Vol 1.4M
3
Quality Score
fail
Mkt Cap
$5.3M
ROE
-247.5%
Margin
-217.5%
D/E
3.44
Beta
2.50
52W
$1–$47

Wall Street Consensus

6 analysts · Mar 2026
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

OTLK
Outlook Therapeutics Inc
$101.3M
LTRN
Lantern Pharma Inc
$33.9M
TVGN
Tevogen Bio Holdings Inc
$65.8M
KTTA
Pasithea Therapeutics Corp
$29.8M
MDCX
Medicus Pharma Ltd
$38.4M
CUE
Cue Biopharma Inc
$27.9M
APLM
Apollomics Inc
$20.6M

Earnings

Beat rate: 25.0%
Next Report May 13, 2026
EPS Estimate: $-2.45
Quarter EPS Est EPS Act Surprise
Mar 2026 $-2.45 — —
Sep 2025 $-2.75 $-4.74 $-1.99
Jun 2025 $-3.06 $-5.10 $-2.04
Mar 2025 $-4.90 $-4.80 +$0.10

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -367.6% -367.6% -367.6% -367.6% -247.5%
P/E (TTM) — — — — — —
Net Margin -319.9% -110.5% -152.2% -152.2% -152.2% -217.5%
Gross Margin 19.9% 34.4% 29.9% 29.9% 29.9% 27.9%
D/E Ratio — 62.00 62.00 62.00 62.00 3.44
Current Ratio 0.64 0.55 0.64 0.64 0.64 3.65

Key Ratios

ROA (TTM)
-207.9%
P/S (TTM)
0.78
P/B
5.5
EPS (TTM)
$-20.74
CF/Share
$-0.95
52W High
$46.53
52W Low
$1.13
$1.13 52-Week Range $46.53

How does BIAF compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

BIAF AAPG ABEO ABOS ABP

BIAF valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.8
▼ 94% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
5.5
▲ 122% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

BIAF profitability vs Biotechnology peers

ROE
-247.5%
▼ 268% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-217.5%
▲ 24% above peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
27.9%
▼ 65% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-207.9%
▼ 345% below peers (-46.7%)
vs Peers
vs Industry
Weak

BIAF financial health vs Biotechnology peers

D/E ratio
3.4
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
3.7
▼ 18% below peers (4.4)
vs Peers
vs Industry
Below avg
Beta
2.5
▲ 158% above peers (1.0)
vs Peers
vs Industry
More volatile

BIAF fundamentals radar

BIAF Peer median Industry

BIAF profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

BIAF vs peers: key metrics

Latest News

No related news yet